The Donald Henry Cameron Novel Therapeutics Program

Literature, news and videos pertinent to
The Donald Henry Cameron Novel Therapeutics Program

Chemo-Sensitivity Testing for Lung Cancer: Dr. Robert Nagourney & Ryan Kuper


Check Out Lung Cancer News Developments


Chemoprevention of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Diagnosis and treatment of bronchial intraepithelial neoplasia and early lung cancer of the central airways: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Diagnostic surgical pathology in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Palliative and end-of-life care in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Treatment of tobacco use in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Tiny capsule effectively kills cancer cells

Life-Saving DNA Test Overlooked in Rise of Colon Cancer

Overview of non small cell lung cancer-clinical trial

For more information about this special program, please click on.....

To support this program, please click below.

Donate

We are always looking for updated RSS newsfeeds for the The Donald Henry Cameron Novel Therapeutics Program at ICAN. If you have suggestions, please email us at DonaldCameronProgram@askican.org.

Please encourage family and friends to join our Cancer Research Literature teams for this Program by emailing ICAN at DonaldCameronProgram@askican.org.  We would like additional Research Team Leaders at ICAN for this named program to be medical students, physicians, nurses, or post-doctoral students in the sciences.  

Web Research Interns for the The Donald Henry Cameron Novel Therapeutics Program are comprised of highly motivated high school students, college students, college graduates, medical students, or employed or retired persons who have the time to help a great cause.  

Please submit two paragraphs about your background and career (and career aspirations) and why you would like to be part of an ICAN Research team.  All positions are "virtual" meaning you work from your home or office computer and email your work in Word (and in some cases Excel, but you need not be fluent in Excel to join us).  

Because ICAN has a global volunteer network, all positions are unpaid.  ICAN is five-star rated on VolunteerMatch.

If you have peer-reviewed citations to SUBMIT to this part of Donald's Program, please email to CitationReviewDonaldCameron@askican.org.

Untitled Document